Drug intelligence / Profile preview

losartan + hydrochlorothiazide

Development stage
Approved
Lead developer
Merck
Modality
Small Molecules
Administration
Oral
01

Overview

**Losartan + hydrochlorothiazide** is an oral fixed-dose antihypertensive combination of losartan, an angiotensin II type 1 receptor blocker, and hydrochlorothiazide, a thiazide diuretic. Losartan reduces angiotensin II-mediated vasoconstriction and aldosterone signaling, while hydrochlorothiazide promotes renal sodium and water excretion through inhibition of sodium-chloride reabsorption in the distal convoluted tubule. The combination is used for hypertension and to reduce stroke risk in patients with hypertension and left ventricular hypertrophy. It is supplied as film-coated tablets, including 50 mg/12.5 mg, 100 mg/12.5 mg, and 100 mg/25 mg strengths. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4116ccde-2e23-45f4-b12f-6337df877744))

Brand names
AnzaplusCozaar CompCozaar Comp ForteCozaar PlusCozaar Plus ForteCosaar PlusFortzaarForzaarHizaarHyzaarHyzaar DSHyzaar Extra ForteHyzaar ForteLoortan PlusLoortan Plus ForteLorzaar PlusLorzaar Plus ForteOcsaar Plus
Other names
HCTZ/losartanhydrochlorothiazide + losartanhydrochlorothiazide/losartanlosartan + hydrochlorothiazidelosartan hydrochlorothiazidelosartan potassium + hydrochlorothiazidelosartan potassium/HCTZlosartan potassium/hydrochlorothiazidelosartan/HCTZlosartan/hydrochlorothiazide
02

Targets

AGTR1 (Angiotensin II Type-1 receptor)SLC12A3 (Thiazide-sensitive sodium-chloride cotransporter)

Beyond the preview

Go deeper on losartan + hydrochlorothiazide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on losartan + hydrochlorothiazide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call